• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.57% Nasdaq Up2.12%

    Haemonetics Corporation (HAE)

    -NYSE
    28.22 Down 0.19(0.67%) Jun 28, 4:01PM EDT
    ProfileGet Profile for:
    Haemonetics Corporation
    400 Wood Road
    Braintree, MA 02184
    United States - Map
    Phone: 781-848-7100
    Website: http://www.haemonetics.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Instruments & Supplies
    Full Time Employees:3,225

    Business Summary 

    Haemonetics Corporation, a healthcare company, provides products for processing, handling, and analysis of blood. The company operates through five segments: North America Plasma; Americas Blood Center and Hospital; Europe, Middle East and Africa; Asia Pacific; and Japan. It offers plasma collection and storage products, including PCS brand plasma collection equipment and disposables, plasma collection containers, and intravenous solutions, as well as information technology platforms for plasma customers to manage their donors, operations, and supply chain; Multicomponent Collection System brand apheresis equipment to collect specific blood components integrated from the donor; Automated Cell Processor brand solution to automate the washing and freezing of red cell components; and whole blood collection, filtration, and processing products. The company also offers hospital products comprising TEG thrombelastograph hemostasis analyzer system, a blood diagnostic instrument that measure a patientÂ’s hemostasis or the ability to form and maintain blood clots; Cell Saver system, a surgical blood salvage system for cardiovascular surgeries; and OrthoPAT surgical blood salvage systems for orthopedic procedures. In addition, it offers SafeTrace Tx, a software solution that manages blood product inventory and transfusion, as well as performs patient cross-matching; and BloodTrack suite of solutions for managing, tracking, and controlling blood products from the hospital blood center through to transfusion to the patient. The company markets and sells its products to bio-pharmaceutical companies, blood collection groups and independent blood centers, hospitals and hospital service providers, group purchasing organizations, and national health organizations through its direct sales force, as well as independent distributors. Haemonetics Corporation was founded in 1971 and is headquartered in Braintree, Massachusetts.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Haemonetics Corporation

    Corporate Governance 
    Haemonetics Corporation’s ISS Governance QuickScore as of Jun 1, 2016 is 6. The pillar scores are Audit: 1; Board: 5; Shareholder Rights: 7; Compensation: 5.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Kent J. Davies , 53
    Chief Operating Officer
    616.00K0.00
    Mr. Byron Selman , 49
    Pres of Global Markets
    528.00K0.00
    Mr. David Fusco , 42
    Exec. VP of Global HR
    422.00K0.00
    Mr. Christopher Simon , 52
    Chief Exec. Officer and Pres
    N/AN/A
    Mr. Dan Goldstein , 39
    Principal Accounting Officer, VP and Corp. Controller
    N/AN/A
    Amounts are as of Dec 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders